These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 16965827

  • 1. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.
    Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL.
    Radiother Oncol; 2006 Oct; 81(1):39-46. PubMed ID: 16965827
    [Abstract] [Full Text] [Related]

  • 2. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [Abstract] [Full Text] [Related]

  • 3. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL.
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [Abstract] [Full Text] [Related]

  • 4. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB, Nasr E, Tucker SL, Brihi E, Zaytoun G, Hadi U, Salem Z, El Saghir N, Issa P, Shamseddine A.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1408-15. PubMed ID: 15817344
    [Abstract] [Full Text] [Related]

  • 5. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI.
    Laryngoscope; 2008 Apr 01; 118(4):663-70. PubMed ID: 18216741
    [Abstract] [Full Text] [Related]

  • 6. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, Law SC, Kam MK, Leung TW, Sham JS, Lee AW, Au JS, Hui EP, Sze WK, Cheng AC, Yau TK, Ngan RK, Wong FC, Au GK, Chan AT, Hong Kong Nasopharyngeal Carcinoma Study Group.
    Head Neck; 2005 May 01; 27(5):397-405. PubMed ID: 15726589
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
    Cao KJ, Li Y, Xie GF, Hong MH.
    Zhonghua Zhong Liu Za Zhi; 2006 Feb 01; 28(2):134-7. PubMed ID: 16750020
    [Abstract] [Full Text] [Related]

  • 8. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM, Leung SF, Tung SY, Zee B, Sham JS, Lee AW, Lau WH, Kwan WH, Leung TW, Chua D, Sze WM, Au JS, Yu KH, O SK, Kwong D, Yau TK, Law SC, Sze WK, Au G, Chan AT.
    Radiother Oncol; 2006 Apr 01; 79(1):27-33. PubMed ID: 16626829
    [Abstract] [Full Text] [Related]

  • 9. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
    Weber DC, Miller RC, Villà S, Hanssens P, Baumert BG, Castadot P, Varlet P, Abacioglu U, Igdem S, Szutowicz E, Nishioka H, Hofer S, Rutz HP, Ozsahin M, Taghian A, Mirimanoff RO.
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):179-86. PubMed ID: 16814953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL.
    Cancer Invest; 2007 Aug 01; 25(5):315-21. PubMed ID: 17661206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
    Wang CT, Cao KJ, Li Y, Xie GF, Huang PY.
    Ai Zheng; 2007 Feb 01; 26(2):212-5. PubMed ID: 17298756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Nakamura T, Kodaira T, Tachibana H, Tomita N, Tomoda T, Nakahara R, Inokuchi H, Mizoguchi N, Takada A, Fuwa N.
    Jpn J Clin Oncol; 2008 Dec 01; 38(12):803-9. PubMed ID: 18840881
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
    Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He S.
    Laryngoscope; 2008 Jul 01; 118(7):1206-10. PubMed ID: 18418278
    [Abstract] [Full Text] [Related]

  • 17. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1356-64. PubMed ID: 18472356
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma.
    Kalogera-Fountzila A, Karanikolas D, Katodritis N, Samantas E, Sarafopoulos A, Ikonomou I, Zamboglou N, Tselis N, Dimitriadis AS, Fountzilas G, AJCC (American Joint Committee on Cancer).
    Strahlenther Onkol; 2006 Aug 01; 182(8):458-66. PubMed ID: 16896592
    [Abstract] [Full Text] [Related]

  • 19. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y.
    Cancer; 2006 Sep 15; 107(6):1287-93. PubMed ID: 16909425
    [Abstract] [Full Text] [Related]

  • 20. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
    Laskar S, Bahl G, Muckaden MA, Nair R, Gupta S, Bakshi A, Gujral S, Shet T, Shrivastava SK, Dinshaw KA.
    Cancer; 2007 Aug 15; 110(4):816-23. PubMed ID: 17582622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.